newsfilter
← Latest News
GlobeNewswire·

Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2021 and Recent Developments

-- Recorded Second Quarter Revenue of $26.1 Million -- -- Initiated Strategic Expansion into Viral Vector Development and Manufacturing Services for Cell and Gene Therapy -- -- Signed $36 Million in New Business Orders and Ended the Quarter with a